Intermittent Hypoxic–Hyperoxic Training During Inpatient Rehabilitation Improves Exercise Capacity and Functional Outcome in Patients With Long Covid: Results of a Controlled Clinical Pilot Trial

Respiratory treatment with IHHT in addition to a multidisciplinary rehabilitation programme improves functional capacity, symptomatic status and quality of life in patients with disabling long COVID. IHHT has been demonstrated to be safe, well tolerated and feasible to be integrated in an inpatient rehabilitation programme to improve outcome in long COVID.

Authors

Institutions

Publication Details

Journal
Journal of Cachexia Sarcopenia and Muscle
Published
2024-11-19
DOI
https://doi.org/10.1002/jcsm.13628
Citations
10
Primary Topic
Long-Term Effects of COVID-19
Type
article
Field-Weighted Citation Impact
3.69

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Intermittent Hypoxic–Hyperoxic Training During Inpatient Rehabilitation Improves Exercise Capacity and Functional Outcome in Patients With Long Covid: Results of a Controlled Clinical Pilot Trial

Andrea Fischer, Jochen Springer, Wolfram Doehner, Per Otto Schueller et al.
10 citations
Journal of Cachexia Sarcopenia and Muscle
Long-Term Effects of COVID-19
3.69
article

Intermittent Hypoxic–Hyperoxic Training During Inpatient Rehabilitation Improves Exercise Capacity and Functional Outcome in Patients With Long Covid: Results of a Controlled Clinical Pilot Trial

Andrea Fischer, Jochen Springer, Wolfram Doehner, Per Otto Schueller, Bin Ahmad Hatib Muhammad Alimi, Jasmin Muhar, Christoph Altmann
article en
10 citations

Abstract

Respiratory treatment with IHHT in addition to a multidisciplinary rehabilitation programme improves functional capacity, symptomatic status and quality of life in patients with disabling long COVID. IHHT has been demonstrated to be safe, well tolerated and feasible to be integrated in an inpatient rehabilitation programme to improve outcome in long COVID.

Journal of Cachexia Sarcopenia and MuscleVol. 15(6)
German Centre for Cardiovascular Research (DE), Berlin Institute of Health at Charité - Universitätsmedizin Berlin (DE), Charité - Universitätsmedizin Berlin (DE)
Amgen, Pfizer, Boston Scientific Corporation, Amarin Corporation, Deutsche Rentenversicherung, Vifor Pharma
Openalex Percentile: Top 6%
Long-Term Effects of COVID-19
3.69
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.